证券代码：600030 证券简称：中信证券 公告编号：临 2025-068 中信证券股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》及《上海证券 交易所上市公司自律监管指引第1号——规范运作》的规定，中信证券股份有限公 司（以下简称公司）编制了截至2025年6月30日A股配股及H股配股募集资金存放与 实际使用情况专项报告。具体如下： 公司经2020年度股东大会、2021年第一次A股类别股东会及2021年第一次H股 类别股东会审议通过，并经中国证券监督管理委员会《关于核准中信证券股份有 限公司配股的批复》 （证监许可〔2021〕3729号）、 《关于核准中信证券股份有限公 司发行境外上市外资股的批复》（证监许可〔2021〕3714号）文件核准，公司向A 股原股东及境外上市外资股股东配售新股，并已分别于2022年1月27日、3月4日成 功完成A股和H股配股工作。 一、募集资金基本情况 （一）募集资金到账情况 其中，公司于上海证券交易所公开发行1,552,021,6 ...

塞力斯医疗科技集团股份有限公司 募集资金管理办法 塞力斯医疗科技集团股份有限公司 募集资金管理办法 （2025 年 8 月） 第一章 总则 第一条 为完善塞力斯医疗科技集团股份有限公司（以下简称"公司"）治 理，规范公司对募集资金的使用和管理，提高募集资金的使用效率和效益，根据 《中华人民共和国公司法》 《中华人民共和国证券法》 （以下简称"《证券法》"）、 《上市公司募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交 易所上市公司自律监管指引第 1 号——规范运作》等法律法规、规章、规范性文 件及《塞力斯医疗科技集团股份有限公司章程》（以下简称"《公司章程》"） 的规定，制定本办法。 第二条 本办法所称募集资金是指公司通过发行股票或者其他具有权益性质 的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励计划 募集的资金。 本办法所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 公司存在两次以上融资的，应当分别设置募集资金专户。超募资金也应当存 放于募集资金专户管理。 募集资金投资境外项目的，除符合第一款规定外，公司及保荐机构还应当采 取有效措施，确保投资于境外项目的募集资 ...

中信证券股份有限公司 关于烟台睿创微纳技术股份有限公司 部分募投项目延期的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为烟台睿 创微纳技术股份有限公司（以下简称"睿创微纳"或"公司"）向不特定对象发 行可转换公司债券并在科创板上市项目的保荐人，根据《证券发行上市保荐业务 管理办法》《上海证券交易所科创板股票上市规则》《上市公司募集资金监管规 则》以及《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关规定，对公司部分募投项目延期的事项进行了核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意烟台睿创微纳技术股份有限 （证监许可〔2022〕2749 号）， 公司向不特定对象发行可转换公司债券注册的批复》 公司获准向不特定对象发行可转换公司债券发行数量为 1,564.69 万张，每张面值 为人民币 100 元，募集资金总额为 156,469.00 万元，扣除承销及保荐费用等与发 行有关的费用共计人民币 989.94 万元后，募集资金净额为 155,479.06 万元。上 述募集资金已全部到位，经信永中和会计师事务所（特殊普通合伙）审验 ...

中国国际金融股份有限公司 关于绝味食品股份有限公司 部分募集资金投资项目结项 经中国证券监督管理委员会出具的《关于核准绝味食品股份有限公司公开发行可转 换公司债券的批复》（证监许可〔2018〕2222 号）核准，公司于 2019 年 3 月公开发行 可转换公司债券 1,000 万张，每张面值 100 元，募集资金总额为人民币 100,000 万元， 扣除发行费用后实际募集资金净额为人民币 98,178.40 万元。上述募集资金已于 2019 年 3 月 15 日全部存入公司募集资金专项账户，并经天职国际会计师事务所（特殊普通 合伙）出具的"天职业字〔2019〕13027 号"《验资报告》审验确认。 为规范募集资金管理，公司及全资子公司天津阿正食品有限公司、江苏阿惠食品有 限公司、武汉阿楚食品有限公司、山东阿齐食品有限公司和海南阿翔食品有限公司已开 设了募集资金专项账户，对募集资金实施专项存储与使用，并与保荐机构、募集资金存 放银行签署了募集资金专户存储三方监管协议。 二、结项募投项目募集资金使用及节余情况 （一）本次结项的募投项目募集资金使用情况 本次拟结项项目为"山东阿齐食品有限公司30,000吨仓储中心建 ...

华泰联合证券有限责任公司（以下简称"华泰联合证券"或"独立财务顾问"） 作为创新新材料科技股份有限公司（以下简称"创新新材"或"公司"，原名为 "北京华联综合超市股份有限公司"）重大资产出售及向特定对象发行股份购买 山东创新金属科技有限公司 100%股权并募集配套资金暨关联交易的独立财务顾 问，根据《上市公司重大资产重组管理办法》 《上海证券交易所股票上市规则》 《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》及《上海证券交易所 上市公司自律监管指引第 11 号——持续督导》等文件的有关规定，对创新新材 募投项目结项并将节余募集资金永久补充流动资金及注销募集资金专户事项进 行了认真、审慎的核查，并发表本核查意见，具体情况如下： 一、募集资金相关情况 根据中国证券监督管理委员会核发的《关于核准北京华联综合超市股份有限 公司重大资产重组及向山东创新集团有限公司等发行股份购买资产并募集配套 资金的批复》（证监许可[2022]2467号)，公司募集配套资金向特定对象发行股票 的数量为332,594,235股，发行价格为人民币4.51元/股，公司募集资金总额为人民 币1,499,999,999.85元，扣 ...

关于鹏欣环球资源股份有限公司 中兴财光华审专字（2025）第 211185 号 目 录 关于鹏欣环球资源股份有限公司 2025 年 1-6 月募集资 金存放与使用情况鉴证报告 鹏欣环球资源股份有限公司关于公司募集资金存放 与实际使用情况的专项报告 关于鹏欣环球资源股份有限公司 中兴财光华审专字（2025）第 211185 号 鹏欣环球资源股份有限公司全体股东： 我们审核了后附的鹏欣环球资源股份有限公司（以下简称"鹏欣资源公司"） 《鹏欣环球资源股份有限公司关于公司募集资金存放与实际使用情况的专项报 告》（以下简称"募集资金专项报告"）。 一、董事会的责任 鹏欣资源公司董事会的责任是按照《上市公司募集资金监管规则》（证监会 公告〔2025〕10 号）、《上海证券交易所上市公司自律监管指引第1号——规范 运作（2025年5月修订）》及相关格式指南的规定编制募集资金专项报告，并保 证其内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对鹏欣资源公司董事会编制的募集 资金专项报告发表意见。 我们按照《中国注册会计师其他鉴证业务准则第3101号——历史 ...

Core Points - The report details the fundraising and usage status of Matsui New Materials Group Co., Ltd. for the first half of 2025, confirming compliance with regulatory requirements and accurate disclosures [1][6][8] Fundraising Overview - The total amount raised from the public offering was RMB 686,152,000, with 1,990,000 shares issued at a price of RMB 34.48 per share [1][2] - After deducting underwriting and related fees totaling RMB 51,760,236.35, the net proceeds amounted to RMB 634,391,763.65, which was fully deposited into a designated account on June 2, 2020 [1][2] Fund Usage and Surplus - As of June 30, 2025, the company had invested RMB 407,116,710.56 into fundraising projects and used RMB 118,000,000 of over-raised funds to permanently supplement working capital [1][3] - The remaining balance of unused fundraising was RMB 149,295,240.96, with RMB 30,000,000 allocated to financial products [2][3] Fund Management - The company established a fundraising management system to ensure efficient use and protection of investor rights, including opening special accounts for fundraising [1][2] - A tripartite supervision agreement was signed with several banks and the underwriting institution to clarify responsibilities and obligations regarding the management of the funds [1][2] Cash Management - The company has utilized temporarily idle fundraising for cash management, with a maximum limit of RMB 580,000,000 approved for investment in low-risk financial products [2][3] - As of June 30, 2025, the balance of idle funds under cash management was RMB 30,000,000, invested in structured deposits [3][4] Use of Over-raised Funds - The company has used RMB 59,000,000 of over-raised funds for permanent working capital supplementation, approved by the board and shareholders [3][4] - The remaining over-raised funds were also allocated for similar purposes without affecting the funding needs of investment projects [4][7] Project Adjustments - The company has made adjustments to the investment amounts and timelines for certain fundraising projects to enhance efficiency and adapt to market conditions [4][7] - The total planned investment for adjusted projects increased by RMB 84,012,500, funded entirely by over-raised funds [4][7] Surplus Fund Usage - The company reported a surplus of RMB 91,724,400 as of December 31, 2024, due to cost savings from improved operational efficiencies and strategic procurement decisions [7][8] - The surplus funds will be allocated to new projects and permanent working capital, as approved by the board and shareholders [7][8]

证券代码：603916 证券简称：苏博特 公告编号：2025-044 转债代码：113650 转债简称：博 22 转债 江苏苏博特新材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》（证监会公告[2012]44 号）、上海证券交易所 发布的《上海证券交易所上市公司募集资金管理办法》及相关格式指引规定， 本公司将截止 2025 年 6 月 30 日募集资金存放与使用情况专项报告如下： 一、 募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）证监许可[2022]1141 号文核准，公司于 2022 年 7 月 2 日公开发行了 800.00 万张可转换公司债券， 每张面值 100 元，发行总额 80,000 万元。经上海证券交易所自律监管决定书 [2022]196 号文同意，公司发行的 80,000.00 万元可转换公司债券于 2022 年 7 月 28 日在上海证券交易所挂牌交易。上述募集资金 ...

Core Points - Jiangsu Hongwei Technology Co., Ltd. reported on the status of its fundraising activities and the use of raised funds for the first half of 2025, ensuring compliance with relevant regulations [2][11]. Fundraising Overview - The company raised a total of RMB 677,387,918.34 from its initial public offering (IPO) by issuing 24,623,334 shares at a price of RMB 27.51 per share, with a net amount of RMB 596,804,289.33 after deducting issuance costs [2][3]. - The company also issued 4,300,000 convertible bonds at a price of RMB 100 each, raising RMB 43,000,000, with a net amount of RMB 42,327,690 after expenses [3]. Fund Usage and Balance - As of June 30, 2025, the remaining unused balance of the raised funds was RMB 1,766,075.01, all stored in designated accounts [6][11]. - The total amount used from the IPO funds was RMB 597,660,946.04, with an additional RMB 4,165.36 accrued from interest income [3][7]. - The company utilized RMB 11,000,000 from excess funds to permanently supplement working capital and RMB 6,000,000 from idle funds for temporary working capital [8][9]. Fund Management - The company has established a three-party supervision agreement with its underwriter and banks to ensure proper management and usage of the raised funds [4][11]. - The company has not engaged in any prior investment or replacement of the raised funds during the reporting period [7][10]. Compliance and Reporting - The company confirmed that it has adhered to all relevant regulations regarding the management and use of raised funds, with no violations or issues in disclosure [11].

Core Viewpoint - The document outlines the fundraising management system of Zhejiang Zhongxin Environmental Protection Technology Group Co., Ltd, emphasizing the importance of regulating the use and management of raised funds to protect investors' interests [1]. Fundraising Management - The company must establish internal control systems for the storage, use, and management of raised funds, ensuring clear regulations on storage, usage, changes, supervision, and accountability [1][2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and must not participate in any unauthorized changes to the fund's purpose [2][3]. Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and this account should not be used for non-fund purposes [7]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received, detailing the management and oversight of the funds [8][9]. Fund Usage - The company must adhere to specific requirements when using raised funds, including clear application procedures, decision-making processes, and risk control measures [9][10]. - Funds should primarily be used for the company's main business, and any financial investments or loans to related parties are prohibited [10][11]. Idle Funds Management - Idle funds can be temporarily used for cash management, provided that the investments are safe and do not affect the normal investment plans [11][12]. - If idle funds are used to supplement working capital, it must be reported and approved by the board, and the funds must be returned to the special account within a specified timeframe [12][13]. Use of Excess Funds - Any excess funds raised beyond the planned amount must be allocated to ongoing or new projects, or for share buybacks, with a clear plan disclosed by the company [13][14]. - The use of excess funds requires board approval and must be disclosed to shareholders, ensuring transparency and accountability [14]. Fund Usage Change - Any changes to the use of raised funds must be approved by the board and the shareholders, with a clear explanation provided for the changes [18][19]. - The company must conduct feasibility analyses for new projects and ensure that they align with the main business objectives [19][20]. Fund Management and Supervision - The company is required to disclose the actual use of raised funds accurately and completely [23]. - The board must conduct semi-annual reviews of the fundraising projects and report on the status of fund usage [24][25]. Compliance and Reporting - Independent directors and the audit committee must monitor the management and usage of raised funds, and can engage external auditors for verification [25][26]. - The sponsor must conduct regular investigations into the management of raised funds and provide reports to the company and the stock exchange [26][27].